Loading viewer...
conference
Format: PDF conference
Tonix Pharmaceuticals presents pharmacokinetic data on TNX-102 SL, a novel sublingual formulation of cyclobenzaprine hydrochloride, at the 2024 Pharmaceutics and Novel Drug Delivery Systems Conference. The oral presentation by Bruce Daugherty, PhD, details the formulation development and bioavailability characteristics of this investigational drug candidate.
investor_presentation
48 Pages
conference
27 Pages
J.B. Hunt Transport Services, Inc.
MD Anderson Targeted Therapy Immunotherapy 2024
conferenceconference
28 Pages
MD Anderson Cancer Center
Delek Logistics Partners 2016 MLP Conference Presentation
conferenceconference
27 Pages
Delek Logistics Partners
U.K. Capital Markets Growth Financing & IPO Routes 2022
conferenceconference
21 Pages
Armstrong Teasdale LLP / Novum Securities Limited